POSA236 Real-World Treatment (Tx) Characteristics for Advanced Non-Small Cell Lung Cancer (aNSCLC) Without Actionable Mutations After Introduction of Immune Checkpoint Inhibitors (ICIs) in EU4 and UK

Authors :: J Multani
V Casey
S Mpima
M Yasuda
CC Chen
F Manuguid
L Kalilani
TJ Giove
J Chao
A Aziez
A Stojadinovic
C Hogea
Source :: Value in Health. 25:S154-S155
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Subjects :: Health Policy
Public Health, Environmental and Occupational Health

Full Text Access

Tools